Even if You Have the Flu, Ignore This Much-Heralded Flu Remedy

Since 2009, Roche, the maker of Tamiflu, has refused to release data from eight of 10 clinical trials on the drug. To address the dangers inherent with withholding of clinical trial data, the Cochrane Collaboration group in collaboration with the British Medical Journal has created the BMJ Open Data Campaign

There is currently no scientific basis for the worldwide recommendation to use Tamiflu for the prevention or treatment of influenza. It is believed, however, that the missing trial data may reveal potential harms, and/or verify the drug’s ineffectiveness

Researchers are calling for an end to the “culture of haphazard publication and incomplete data disclosure,” the implementation of more robust regulation, and full access to the raw trial data to ensure transparency

For more information: Science Behind Tamiflu Recommendations “Missing in Action”